NCT04285983View on ClinicalTrials.gov

"Specified Drug-Use Survey of Trelagliptin Tablets Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease"

CompletedOBSERVATIONAL
Enrollment

89

Participants

Timeline

Start Date

March 1, 2020

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

Trelagliptin

Trelagliptin tablets

Trial Locations (1)

Unknown

Takeda Selected Site, Tokyo

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04285983 - "Specified Drug-Use Survey of Trelagliptin Tablets Survey on Long-term Use in Type 2 Diabetes Mellitus Patients With Severe Renal Impairment or End-stage Renal Disease" | Biotech Hunter | Biotech Hunter